Meeting Coverage:

Aspen Retinal Detachment Society

ARDS: 2021

The Promise of Macular Reconstruction

Show Description +

Timothy Olsen, MD, takes a close look at the preclinical data suggesting macular reconstruction can preserve visual structures in pig eyes–and how that might translate to human applications in the future.

Posted: 2/23/2021

Up Next

An Update on Brolucizumab One Year Later

Ryan Rich, MD; Timothy G. Murray, MD


Diabetic Retinopathy: Treat Them Early

Maria H. Berrocal, MD; Timothy G. Murray, MD

Track the History–and Future–of Anti-VEGF

Robert Avery, MD; Timothy G. Murray, MD

ARDS Stays In-Person, Safely

Timothy G. Murray, MD, MBA

An Update on Surgical Approaches to Gene and Cell Therapies

Allen C. Ho, MD, Timothy G. Murray, MD, MBA

ROP in the Era of Anti-VEGF

R.V. Paul Chan, MD, MSc, MBA, FACS, Timothy G. Murray, MD, MBA

Advancements in Retinal Detachment Repair

Maria H. Berrocal, MD, Timothy G. Murray, MD, MBA

The Promise of Macular Reconstruction

Timothy W. Olsen, MD, Timothy G. Murray, MD, MBA

The Promise of Macular Reconstruction

Timothy Olsen, MD, takes a close look at the preclinical data suggesting macular reconstruction can preserve visual structures in pig eyes–and how that might translate to human applications in the future.

Posted: 2/23/2021


Please log in to leave a comment.

More From ARDS: 2021 Coverage

An Update on Brolucizumab One Year Later

Ryan Rich, MD; Timothy G. Murray, MD

Diabetic Retinopathy: Treat Them Early

Maria H. Berrocal, MD; Timothy G. Murray, MD

Track the History–and Future–of Anti-VEGF

Robert Avery, MD; Timothy G. Murray, MD